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Introduction: Gold nanorods (AuNRs) are an excellent 
material for biomedical applications, especially in 
photothermal therapy for cancer [Alkilany AM. Adv. 
Drug Deliv Rev. 2012; 64:190-199.]. In AuNR synthesis, 
the surfactant cetyltrimethyl ammonium bromide (CTAB) 
easily dissociate, resulting in severe cytotoxicity and low 
stability. Coating silica on AuNRs may solve the 
problems and also make it possible to conjugate targeting 
ligands to AuNRs. But the shape and thickness control 
and functionalization of silica shell pose challenges for 
silica deposition. The reported methods in literature for 
coating silica often lack reproducibility and require 
precise control of CTAB concentration in AuNR stock 
solution [Wu CL. Langmuir. 2009; 25:9441-46]. In this 
investigation, a facile method to synthesize AuNR with 
high uniformity and ease control of their dimensions was 
developed. For internalization of nanoparticles in cancer 
cells, the particle surface was modified with a ligand. The 
biological performance, including biocompatibility, 
cancer cell targeting and sensing was evaluated. 
Methods: AuNRs were synthesized by a modified seed-
mediated growth method using binary surfactants. To 
form mesoporous silica shell on AuNRs, highly diluted 
tetraethyl orthosilicate (TEOS) in ethanol was the 
precursor and surfactants adsorbed on AuNR surface were 
used. The amounts of TEOS/ethanol solution and CTAB 
were studied in forming the silica shell. To functionalize 
the surface of AuNR@mSiO2 nanoparticles (NPs) with 
amino groups, AuNR@mSiO2 NPs were refluxed in 
boiled ethanol containing (3-aminopropyl) triethoxysilane 
(APTES). Folic acid was then conjugated to amino groups 
on the silica shell. After removal of CTAB via refluxing 
in NH3NO3 and ethanol solution, anticancer drug 
doxorubicin hydrochloride (DOX) was loaded into 
mesopores of AuNR@mSiO2 NPs. Drug release 
behaviors were subsequently studied. Hela cells were 
used for assessing the biological performance of the NPs, 
with MCF-7 cells being used for the control experiments. 
Results: This investigation used binary surfactants 
(sodium oleate and CTAB) in the growth solution to tune 
the dimensions of AuNRs. The synthesized AuNRs 
showed high uniformity with 70 nm in length and 25 nm 
in diameter, having negligible impurities (e.g. spherical 
NPs). Previous studies hardly obtained a highly uniform 
silica coating and proper thickness. In this investigation, a 
modified method was used and through optimizing the 
process and concentration of reactants and surfactants, 
AuNR@mSiO2 NPs had a silica coating with uniform and 
controllable thickness (Fig.1a). Mesopores in this coating 
were observed under TEM. Through amine 
functionalization and EDC/NHS catalysis, folic acid was 
conjugated to AuNR@mSiO2 NPs (Fig.1b). After coating 
silica, the maximum longitudinal SPR wavelength red-
shifted slightly but was still in the near-infrared region. 
Upon laser irradiation, AuNR@mSiO2 suspensions 
exhibited temperature increases due to the photothermal 
effect of the AuNR core in AuNR@mSiO2 NPs. The drug 
release from AuNR@mSiO2 was also highly promoted 
under laser irradiation. These results indicated that 
AuNR@mSiO2 NPs could not only serve as a good drug 
carrier but also provide an external stimulus-controlled 
drug release mechanism. Folate receptor (FR) commonly 
expresses on the surface of many human cancer cells such 
as cervical cancer cell (Hela cells). Folic acid displays 
high affinity for FR. Dark-field image of Hela cells after 
incubation with NPs is shown in Fig.2a. Hela cells were 
covered by strong yellow light scattered from FA-
conjugated AuNR@mSiO2 NPs, as compared with weak 
red light from MCF-7 cells. The encapsulation of 
rhodamine 6G (a Raman reporter) in AuNR@mSiO2 NPs 
which emitted red fluorescence had enabled fluorescent 
imaging to study the cellular uptake and targeting ability 
of these NPs. As shown in Fig.2b, strong red fluorescence 
in Hela cells could be clearly seen, indicating that some 
FA-conjugated AuNR@mSiO2 NPs had crossed the cell 
membrane and entered the cytoplasm of Hela cells. In the 
control group, negligible fluorescent signals were shown 
in MCF-7 cells. These results indicated that the NPs could 
be specifically taken up by Hela cells as effective optical 
probes. 
 
 
 
 
 
 
 
 
 
Fig. 1. AuNR@mSiO2 NPs: (a) TEM image, (b) FTIR 
spectrum after folic acid conjugation. 
 
 
 
 
 
 
 
 
Fig. 2. In vitro results for Hela cells after incubation with 
functionalized AuNR@mSiO2 NPs: (a) dark-field image, 
fluorescence image. 
Conclusions:  A facile method was developed to fabricate 
folic acid conjugated AuNR core-mesoporous silica shell 
(AuNR@mSiO2) NPs as multifunctional theranostics. In 
vitro release results showed that the nanodevice was an 
effective drug carrier and provided controlled drug 
release. In vitro biological results demonstrated that the 
nanodevice possessed good targeting and optical ability as 
effective probe for cancer detection. 
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